HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eduardo Díaz-Rubio Selected Research

Paronychia

1/2012First-line cetuximab plus capecitabine in elderly patients with advanced colorectal cancer: clinical outcome and subgroup analysis according to KRAS status from a Spanish TTD Group Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eduardo Díaz-Rubio Research Topics

Disease

40Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2002
27Neoplasms (Cancer)
01/2021 - 05/2002
14Breast Neoplasms (Breast Cancer)
01/2017 - 01/2005
7Neoplasm Metastasis (Metastasis)
01/2018 - 08/2002
6Disease Progression
02/2013 - 06/2004
5Colonic Neoplasms (Colon Cancer)
11/2018 - 06/2004
5Diarrhea
01/2012 - 09/2007
4Circulating Neoplastic Cells
01/2019 - 11/2006
4Hand-Foot Syndrome
01/2012 - 09/2007
4Neutropenia
04/2008 - 06/2004
3Ovarian Neoplasms (Ovarian Cancer)
01/2019 - 05/2007
2Rectal Neoplasms (Rectal Cancer)
11/2018 - 01/2016
2Microsatellite Instability
01/2018 - 07/2002
2Hemorrhage
01/2015 - 04/2012
2Sarcoma (Soft Tissue Sarcoma)
04/2014 - 08/2010
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2014 - 07/2009
2Carcinogenesis
10/2007 - 11/2006
2Neoplasm Micrometastasis
09/2006 - 01/2005
1Pain (Aches)
01/2021
1Adenocarcinoma
01/2019
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2019
1Hypoxia (Hypoxemia)
01/2018
1Liver Diseases (Liver Disease)
01/2018
1Lung Neoplasms (Lung Cancer)
01/2016
1Renal Cell Carcinoma (Grawitz Tumor)
01/2015
1Genomic Instability
02/2014
1Adenocarcinoma of Lung
02/2014
1Osteosarcoma (Osteogenic Sarcoma)
02/2014
1Fibrosis (Cirrhosis)
02/2013
1Hepatocellular Carcinoma (Hepatoma)
02/2013
1Thrombosis (Thrombus)
05/2012
1Solitary Kidney
04/2012
1Hematoma
04/2012
1Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2012
1Paronychia
01/2012

Drug/Important Bio-Agent (IBA)

15Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2020 - 10/2002
14Fluorouracil (Carac)FDA LinkGeneric
11/2020 - 08/2003
10Capecitabine (Xeloda)FDA Link
05/2014 - 06/2004
9XELOXIBA
01/2012 - 06/2004
8Irinotecan (Camptosar)FDA LinkGeneric
11/2020 - 08/2003
8Bevacizumab (Avastin)FDA Link
11/2020 - 01/2005
7Cetuximab (Erbitux)FDA Link
01/2019 - 11/2007
7ErbB Receptors (EGF Receptor)IBA
01/2019 - 11/2007
6Leucovorin (Folinic Acid)FDA Link
11/2020 - 01/2007
5Proteins (Proteins, Gene)FDA Link
01/2018 - 05/2002
5Trastuzumab (Herceptin)FDA Link
10/2014 - 10/2005
4Biomarkers (Surrogate Marker)IBA
11/2020 - 08/2010
3Biological ProductsIBA
01/2021 - 10/2009
3EnzymesIBA
01/2020 - 03/2012
3PlatinumIBA
01/2019 - 10/2002
3Codon (Codons)IBA
01/2019 - 12/2012
3DNA (Deoxyribonucleic Acid)IBA
01/2019 - 04/2011
3thiamine triphosphorate (TTP)IBA
09/2007 - 06/2004
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2006 - 01/2005
2AntioxidantsIBA
01/2020 - 01/2018
2Superoxide DismutaseIBA
01/2020 - 01/2018
2TrabectedinIBA
01/2019 - 05/2007
2Pharmaceutical PreparationsIBA
01/2018 - 12/2008
2AntibodiesIBA
04/2014 - 09/2006
2Telomerase (Telomerase Reverse Transcriptase)IBA
02/2014 - 10/2009
2Monoclonal AntibodiesIBA
12/2012 - 08/2010
2Sunitinib (Sutent)FDA Link
04/2012 - 01/2010
2LigandsIBA
08/2010 - 10/2002
2GemcitabineFDA Link
12/2009 - 08/2002
2Transaminases (Aminotransferases)IBA
05/2009 - 05/2007
1ChemokinesIBA
01/2020
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2020
1adhesion receptorIBA
01/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
01/2020
1Angiogenesis InhibitorsIBA
01/2019
1antiarrhythmic peptide (AAP)IBA
01/2019
1Panitumumab (Vectibix)FDA Link
01/2019
1Dihydrotachysterol (AT 10)IBA
12/2018
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
01/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
1Tumor Biomarkers (Tumor Markers)IBA
01/2017
1Circulating Tumor DNAIBA
01/2017
1alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA
01/2016
1Vitamin D-Binding ProteinIBA
01/2016
1EpiregulinIBA
12/2015
1Formaldehyde (Formol)FDA Link
12/2015
1ParaffinIBA
12/2015
1Messenger RNA (mRNA)IBA
12/2015
1AmphiregulinIBA
12/2015
1pazopanibFDA Link
01/2015
1Lapatinib (GW572016)FDA Link
10/2014
1human ERBB2 proteinIBA
10/2014
1Sorafenib (BAY 43-9006)FDA Link
02/2013
1Blood Proteins (Serum Proteins)IBA
05/2012
1apolipoprotein A-IV (apolipoprotein AIV)IBA
05/2012
1AnthracyclinesIBA
03/2012

Therapy/Procedure

22Drug Therapy (Chemotherapy)
01/2022 - 05/2005
22Therapeutics
01/2022 - 06/2004
3Adjuvant Chemotherapy
01/2016 - 07/2009
2Neoadjuvant Therapy
01/2016 - 08/2009
2Aftercare (After-Treatment)
01/2015 - 01/2008
1Immunotherapy
01/2020
1Salvage Therapy
01/2019
1Palliative Care (Palliative Therapy)
01/2016
1Radiotherapy
01/2015